SLU-PP-332 is a small-molecule agonist of estrogen-related receptors, ERR alpha, beta and gamma, in research. It is not a peptide or the PPAR-delta agent described in the earlier incorrect text.
What exercise mimetic means in this research
It describes selected experimental responses compared with exercise. It does not establish replacement of exercise or performance enhancement in humans.
What level of evidence is cited
Billon and colleagues studied mouse models of obesity and metabolic syndrome. Mouse energy-metabolism findings are not clinical efficacy or safety evidence for an SA product in humans.
SLU and SLP wording in the SA entry
The SA legacy URL and artwork use SLP-PP-332, whereas the research uses SLU-PP-332. Label and identity evidence are needed to confirm equivalence. Earlier mention of Methylene Blue does not establish the formulation or combined effects.
Frequently asked questions
Is SLU-PP-332 a peptide?
No. It is a small molecule studied at ERR receptors.
Are ERR and PPAR-delta the same target?
No. The cited work concerns ERR; PPAR-delta information should not be substituted.
Does this study establish human benefits?
No. The cited study uses animal models.
Read next
SLU-PP-332 / SLP-PP-332 — SA Anabolic · What is MOTS-c? Mitochondrial peptide and evidence · What is AOD-9604? HGH-related structure and weight evidence
Sources
Information checked 10 September 2026. Research and medicine labels above are separate from evidence for this listing image.
For general name or label questions, contact LINE: @musclestationth
Revision note
Earlier community-sourced use figures, performance promises and combination advice remain withdrawn.